<DOC>
	<DOCNO>NCT01341470</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single multiple dos LY2495655 administer subcutaneously intravenously Japanese subject .</brief_summary>
	<brief_title>A Study LY2495655 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria Single dose cohort Overtly healthy male female , determine medical history physical examination Between age 24 50 year Multiple dose cohort Sedentary male females stable medical problem , , , investigator 's opinion , place subject increase risk participate study interfere interpretation data Between age 50 85 year Score &lt; 600 Metabolic Equivalent Tasks ( METs ) per week base International Physical Activity Questionnaire ( IPAQ ) All subject Male subject : agree use reliable method birth control Female subject : woman childbearing potential due surgical sterilization ( least 6 week post surgical bilateral oophorectomy without hysterectomy tubal ligation ) confirm medical history , menopause Up third generation Japanese , define subject 's biological grandparent exclusive Japanese descent born Japan Are ambulatory able perform stair climb test Have clinical laboratory test within normal reference range population investigator site , result acceptable deviation judge clinically significant investigator Have venous access sufficient allow blood sample and/or administration investigational product intravenous administration Single dose cohort Intend use counter prescription medication within 14 day prior dose 2 month dose except thyroid replacement hormone nonabsorbed topical preparation per investigator instruction Abnormal supine blood pressure define diastolic blood pressure &gt; 90 mmHg and/or systolic blood pressure &gt; 140 mmHg Multiple dose cohort If take medication , subject stable least 3 month , time require produce stable effect drug Abnormal supine blood pressure define &gt; 100 mmHg and/or systolic blood pressure &gt; 160 mmHg All subject Have know allergy LY2495655 , related compound component formulation Have history presence cardiovascular , respiratory ( include moderate severe restrictive lung disease obstructive disease , chronic bronchitis , symptomatic asthma ) , hepatic , renal , gastrointestinal , endocrine , hematological , neurological disorder capable constitute risk take study medication interfere interpretation data Have history seizure convulsion , exclude febrile convulsion childhood Subjects underlying muscle disease history muscle disease ( example , polymyositis rhabdomyolysis ) Evidence recent history significant active psychiatric disease schizophrenia , depression , bipolar disorder Recent immobilization major trauma leg within 6 month Knee hip replacement low extremity amputation Participate , participate within 3 month study drug administration , regular resistance training program plan participate exercise program study Actively work physically demand profession Have contraindication MRI scan Tattoos right leg tattoo least 20 year old may ironcontaining pigment Electrocardiogram ( ECG ) consider outside normal limit study population investigator relevant interpretation indicate cardiac disease Clinically significant abnormality neurologic neurocognitive examination screen</criteria>
	<gender>All</gender>
	<minimum_age>24 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>